These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25023470)

  • 21. Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome.
    Kwak-Kim J; Agcaoili MS; Aleta L; Liao A; Ota K; Dambaeva S; Beaman K; Kim JW; Gilman-Sachs A
    Am J Reprod Immunol; 2013 Jun; 69(6):596-607. PubMed ID: 23521391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
    Pierangeli SS; Erkan D
    Lupus; 2010 Apr; 19(4):475-85. PubMed ID: 20353991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome.
    Wijetilleka S; Scoble T; Khamashta M
    Curr Opin Rheumatol; 2012 Sep; 24(5):473-81. PubMed ID: 22585233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies Against Complement Components: Relevance for the Antiphospholipid Syndrome-Biomarkers of the Disease and Biopharmaceuticals.
    Bećarević M
    Curr Rheumatol Rep; 2017 Jul; 19(7):40. PubMed ID: 28631067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid antibody syndrome.
    Kutteh WH; Hinote CD
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):113-32. PubMed ID: 24491987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological manifestations of the antiphospholipid syndrome: risk assessments and evidence-based medicine.
    Muscal E; Brey RL
    Int J Clin Pract; 2007 Sep; 61(9):1561-8. PubMed ID: 17596187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.
    Oku K; Amengual O; Atsumi T
    Eur J Clin Invest; 2012 Oct; 42(10):1126-35. PubMed ID: 22784367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seronegative antiphospholipid syndrome.
    Nayfe R; Uthman I; Aoun J; Saad Aldin E; Merashli M; Khamashta MA
    Rheumatology (Oxford); 2013 Aug; 52(8):1358-67. PubMed ID: 23502076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a role for immunosuppression in antiphospholipid syndrome?
    Sevim E; Willis R; Erkan D
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):426-432. PubMed ID: 31808842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
    Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
    Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies?
    Alijotas-Reig J; Vilardell-Tarres M
    Obstet Gynecol Surv; 2010 Jan; 65(1):39-45. PubMed ID: 20040128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity.
    Samarkos M; Mylona E; Kapsimali V
    Semin Arthritis Rheum; 2012 Aug; 42(1):66-9. PubMed ID: 22405029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis and management of antiphospholipid syndrome.
    Arachchillage DRJ; Laffan M
    Br J Haematol; 2017 Jul; 178(2):181-195. PubMed ID: 28339096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment in patients with antiphospholipid antibodies.
    Bertero M; Kuzenko A
    Minerva Med; 2013 Dec; 104(6):639-48. PubMed ID: 24316917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid syndrome: an update for clinicians and scientists.
    Vreede AP; Bockenstedt PL; Knight JS
    Curr Opin Rheumatol; 2017 Sep; 29(5):458-466. PubMed ID: 28538012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
    Girardi G; Redecha P; Salmon JE
    Nat Med; 2004 Nov; 10(11):1222-6. PubMed ID: 15489858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical advances of interest in the diagnosis and treatment of patients with antiphospholipid syndrome.
    Rodríguez García JL; Khamashta MA
    Rev Clin Esp (Barc); 2013 Mar; 213(2):108-13. PubMed ID: 22673391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.
    Munakata Y; Saito T; Matsuda K; Seino J; Shibata S; Sasaki T
    Thromb Haemost; 2000 May; 83(5):728-31. PubMed ID: 10823270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.